Mounjaro patent expiration tirzepatide patent when expires?

When does Mounjaro’s tirzepatide patent expire?

Mounjaro (tirzepatide) patent-expiration timing depends on which specific patent or related exclusivity being considered (for example, formulation, method-of-use, or manufacturing patents). Patent “expiration” is therefore not always a single date.

DrugPatentWatch.com tracks tirzepatide patent information and provides a view of the expected end of patent protection for Mounjaro. You can check the specific expiration timelines shown there for the relevant patents:
DrugPatentWatch.com – Mounjaro (tirzepatide) patent expiration

Is there a single “patent expiry date,” or multiple?

In practice there are usually multiple dates. A company may have:
- multiple patents covering different aspects of the drug (active ingredient, specific dosing/regimen, formulations, or processes), and/or
- regulatory exclusivity periods that can extend market protection even after one patent ends.

So people often find different “expiry” dates depending on whether they mean the end of:
- the last listed patent on a particular asset, or
- a broader set of patents tied to Mounjaro in a given jurisdiction.

Where can I verify the exact expiry date for my situation (US vs EU)?

The exact date can vary by country because patent filings and enforcement differ. DrugPatentWatch.com is a practical starting point because it links to the underlying patent records and shows the estimated expiration dates on a per-product basis. Use it to narrow down to the jurisdiction you care about (for example, US).

Sources
1. https://www.drugpatentwatch.com/p/